These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 11028948
1. Inhibition of LDL oxidation and oxidized LDL-induced cytotoxicity by dihydropyridine calcium antagonists. Sevanian A, Shen L, Ursini F. Pharm Res; 2000 Aug; 17(8):999-1006. PubMed ID: 11028948 [Abstract] [Full Text] [Related]
3. Comparative cytoprotective effect of dihydropyridine calcium channel blockers against the toxicity of oxidized low density lipoprotein for cultured lymphoid cells. Nègre-Salvayre A, Fitoussi G, Troly M, Salvayre R. Biochem Pharmacol; 1992 Dec 15; 44(12):2379-86. PubMed ID: 1472103 [Abstract] [Full Text] [Related]
4. alpha-Tocopherol, ascorbic acid, and rutin inhibit synergistically the copper-promoted LDL oxidation and the cytotoxicity of oxidized LDL to cultured endothelial cells. Nègre-Salvayre A, Mabile L, Delchambre J, Salvayre R. Biol Trace Elem Res; 1995 Dec 15; 47(1-3):81-91. PubMed ID: 7779579 [Abstract] [Full Text] [Related]
5. Structure-function relationships of calcium antagonists. Effect on oxidative modification of low density lipoprotein. Rojstaczer N, Triggle DJ. Biochem Pharmacol; 1996 Jan 26; 51(2):141-50. PubMed ID: 8615882 [Abstract] [Full Text] [Related]
6. Protection by Ca2+ channel blockers (nifedipine, diltiazem and verapamil) against the toxicity of oxidized low density lipoprotein to cultured lymphoid cells. Nègre-Salvayre A, Salvayre R. Br J Pharmacol; 1992 Nov 26; 107(3):738-44. PubMed ID: 1472971 [Abstract] [Full Text] [Related]
10. Oxidized low-density lipoprotein increases the production of intracellular reactive oxygen species in endothelial cells: inhibitory effect of lacidipine. Cominacini L, Garbin U, Pasini AF, Davoli A, Campagnola M, Pastorino AM, Gaviraghi G, Lo Cascio V. J Hypertens; 1998 Dec 26; 16(12 Pt 2):1913-9. PubMed ID: 9886877 [Abstract] [Full Text] [Related]
11. In vitro antioxidant activity of calcium antagonists against LDL oxidation compared with alpha-tocopherol. Lupo E, Locher R, Weisser B, Vetter W. Biochem Biophys Res Commun; 1994 Sep 30; 203(3):1803-8. PubMed ID: 7945331 [Abstract] [Full Text] [Related]
12. alpha-Tocopherol and trolox block the early intracellular events (TBARS and calcium rises) elicited by oxidized low density lipoproteins in cultured endothelial cells. Mabile L, Fitoussi G, Periquet B, Schmitt A, Salvayre R, Nègre-Salvayre A. Free Radic Biol Med; 1995 Aug 30; 19(2):177-87. PubMed ID: 7649489 [Abstract] [Full Text] [Related]
14. Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic. Fuhrman B, Volkova N, Rosenblat M, Aviram M. Antioxid Redox Signal; 2000 Aug 30; 2(3):491-506. PubMed ID: 11229363 [Abstract] [Full Text] [Related]
15. Protection of low density lipoprotein oxidation at chemical and cellular level by the antioxidant drug dipyridamole. Iuliano L, Colavita AR, Camastra C, Bello V, Quintarelli C, Alessandroni M, Piovella F, Violi F. Br J Pharmacol; 1996 Dec 30; 119(7):1438-46. PubMed ID: 8968553 [Abstract] [Full Text] [Related]
20. Impact of a combination of a calcium antagonist and a beta-blocker on cell- and copper-mediated oxidation of LDL and on the accumulation and efflux of cholesterol in human macrophages and murine J774 cells. Lesnik P, Dachet C, Petit L, Moreau M, Griglio S, Brudi P, Chapman MJ. Arterioscler Thromb Vasc Biol; 1997 May 30; 17(5):979-88. PubMed ID: 9157964 [Abstract] [Full Text] [Related] Page: [Next] [New Search]